Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03289741
Title A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
Recruitment Completed
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.